Industry reports
Editor highlights

Publication dates

All regions

Generics Research Reports, April 2014

You might be interested in: gas exploration, drug, gas, more »


 

1-20 of about 3 200 reports for Generics
Generic Sweden AB

Generic Sweden AB

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... Price/earnings, price/book, price/sales and 52-week price change) and financial position (long-term debt/equity). Also included for generic sweden ab are the company description, recent stock ...

Amphastar Pharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

Amphastar Pharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2014
  • by Global Data

... Is a specialty and generic pharmaceutical company which focuses on the development, manufacturing and marketing of proprietary and generic injectable and inhalation products. Amphastar's products include ...

Global Generic Drugs Market 2014-2018

Global Generic Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

... Profit margins, increase pricing pressure, and pose a challenge to the growth of this market. Technavio's report, the global generic drugs market 2014-2018, has been prepared based on an in ...

Dexmedetomidine  - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

  • $ 1 300
  • Company report
  • March 2014
  • by Generics Web - Selector 44

... Are for a particular generic product in the us.# 'Patent risk analysis' section containing three graphical displays of data drawn from known patent filings to provide valuable competitor insight and development ...

Dexmedetomidine  - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

  • $ 550
  • Company report
  • March 2014
  • by GenericsWeb - Selector 7

... To provide an indication of the key patents pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive patent search can be found in the corresponding pipeline selector ...

Liraglutide  - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

Liraglutide - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

  • $ 500
  • Company report
  • March 2014
  • by GenericsWeb - Selector 7

... Pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive patent search can be found in the corresponding pipeline selector report). **General drug information ...

Liraglutide  - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

Liraglutide - Key patent, SPC, and data exclusivity expiry (44 country coverage), Generics Web - Selector 44

  • $ 1 200
  • Company report
  • March 2014
  • by Generics Web - Selector 44

... To provide an indication of the key patents pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive patent search can be found in the corresponding pipeline selector ...

Alendronic Acid (Ext) - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

Alendronic Acid (Ext) - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

  • $ 500
  • Company report
  • March 2014
  • by GenericsWeb - Selector 7

... Indicatorthe 'key patent indicator' section is intended only to provide an indication of the key patents pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive ...

Cetuximab - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

Cetuximab - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

  • $ 500
  • Company report
  • March 2014
  • by GenericsWeb - Selector 7

... Key patent indicatorthe 'key patent indicator' section is intended only to provide an indication of the key patents pertaining to a generic drug, and is not based on a comprehensive patent search (a ...

Galantamine - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

Galantamine - Key patent, SPC, and data exclusivity expiry (7 country coverage), GenericsWeb - Selector 7

  • $ 500
  • Company report
  • March 2014
  • by GenericsWeb - Selector 7

... Key patent indicatorthe 'key patent indicator' section is intended only to provide an indication of the key patents pertaining to a generic drug, and is not based on a comprehensive patent search (a ...

» View Public Reports

About 4 100 reports for Generics

The Japanese Generic Drug Industry

  • Industry report
  • May 2012
  • 42 pages

» Read our Company Profiles

5 Companies for Generics

GlaxoSmithKline P.L.C.

United States

Icon Group

United States

Novartis Inc.

Switzerland

Bayer AG

Germany

Mylan Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.